Achieve Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2020

The following table summarizes our contractual obligations as of September 30, 2020 (in thousands):

	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years
Vancouver office operating lease	$	150	$	16	$	129	$	5	$	—
Seattle office operating lease	$	62	$	37	$	25	$	—	$	—
Total	$	212	$	53	$	154	$	5	$	—

Other information related to leases was as follows:

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2020			2019			2020			2019
Supplemental Cash Flows Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	47		$	42		$	137		$	133
Right-of-use assets obtained in exchange for lease obligations:
Operating leases		—			—			—			455
Weighted Average Remaining Lease Term
Operating leases	1.75 years			2.36 years			1.75 years			2.36 years
Weighted Average Discount Rate
Operating leases		9.9	%		9.9	%		9.9	%		9.9	%

Future minimum lease payments under the Vancouver lease are as follows (in thousands):

The future minimum annual lease payments under the Seattle Lease are as follows (in thousands):